Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Stomatitis 2Mucositis 2Head and Neck Neoplasms 2Signs and Symptoms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neuroblastoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Metabolic Diseases 1Lymphoma 1Leukemia, Myeloid, Acute 1Immunologic Deficiency Syndromes 1Hepatoblastoma 1Anemia, Refractory, with Excess of Blasts 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 6Granulocyte Colony-Stimulating Factor 5Melphalan 4Etoposide 4Cisplatin 4Carboplatin 4sodium thiosulfate 3fludarabine 3Thiotepa 3Mesna 3Filgrastim 3Busulfan 3pembrolizumab 2Vorinostat 2Vincristine 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Ifosfamide 2Gemcitabine 2Fluorouracil 2Doxorubicin 2talazoparib 1sintilimab 1sargramostim 1pegylated granulocyte colony-stimulating factor 1omburtamab I-131 1lenvatinib 1irinotecan sucrosofate 1fludarabine phosphate 1etoposide phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hepatoblastoma × Honey × Clear all
NCT01804634 2026-03-13

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
60 enrolled
CNSGastrointestinalSarcoma

Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡